Sugi Predict

Sugi Predict / Compounds / SCHEMBL4068034

SCHEMBL4068034

SCHEMBL4068034

CC1CC([C@H](C[C@H](O)[C@@H](N)Cc2ccccc2)C(N)=O)CC(C)O1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 8/20 0.58
▸ CSNK1E P49674 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ SLC15A1 P46059 1/20 0.38
▸ LAP3 P28838 2/20 0.36
▸ REN P00797 2/20 0.36
▸ ANPEP P15144 1/20 0.36
▸ RNPEP Q9H4A4 1/20 0.36
▸ DNPEP Q9ULA0 1/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ ALPI P09923 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ XIAP P98170 1/20 0.35
▸ SLC7A5 Q01650 1/20 0.35
▸ SLC1A3 P43003 1/20 0.35
▸ SLC1A2 P43004 1/20 0.35
▸ SLC1A1 P43005 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065263 0.88 CCR1 (0.46) CCR1CSNK1ESLC15A1LAP3REN
SCHEMBL4062299 0.87 CCR1 (0.47) CCR1SLC1A1
SCHEMBL4060521 0.84 CCR1 (0.47) CCR1EPHX1
SCHEMBL4066838 0.84 CCR1 (0.50) CCR1KMT2A
SCHEMBL4068618 0.82 CCR1 (0.55) CCR1CSNK1ESLC15A1EPHX1ALPI
SCHEMBL4072849 0.81 CCR1 (0.57) CCR1CSNK1ESLC15A1LAP3REN
SCHEMBL4061506 0.81 LMNA (0.46) CCR1CSNK1ESLC15A1LAP3REN
SCHEMBL4066052 0.81 CCR1 (0.42) CCR1CSNK1ESLC15A1LAP3REN
SCHEMBL7586283 0.81 CCR1 (0.56) CCR1CSNK1EKMT2ASLC15A1ANPEP
SCHEMBL4067461 0.81 CCR1 (0.56) CCR1CSNK1EKMT2ASLC15A1ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966443-B1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR PFIZER (US) 2009-01-28 — — EP disclosed
US-20020198207-A1 Novel Hexanoic acid derivatives KATH JOHN CHARLES (US) 2002-12-26 — — US disclosed
US-6403587-B1 AUTOIMMUNE DISEASES, ACUTE AND CHRONIC INFLAMMATORY CONDITIONS, ALLERGIC CONDITIONS, INFECTION ASSOCIATED WITH INFLAMMATION, VIRAL, TRANSPLANTATION TISSUE REJECTION, ATHEROSCLEROSIS, RESTENOSIS, HIV INFECTIVITY, AND PFIZER INC. 2002-06-11 — — US disclosed
EP-0966443-A1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR PFIZER INC. (US) 1999-12-29 — — EP disclosed
WO-1998038167-A1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR PFIZER INC. (US) 1998-09-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198207-A1 Novel Hexanoic acid derivatives HCAR3, HCAR1, FFAR1 CCR1 21/4885CSNK1E 3498/4885KMT2A 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.